Protein kinase CK2 inhibitors: a patent review

Author： Cozza Giorgio   Pinna Lorenzo A   Moro Stefano  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.9, 2012-09, pp. : 1081-1097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1340-1351

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C inhibitors: a patent review (2010 – present)

By Sobhia Masilamani Elizabeth   Grewal Baljinder K   Paul Matam Losery Stanly   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1451-1468

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase C inhibitors: a patent review (2008 – 2009)

By Sobhia M Elizabeth   Grewal Baljinder K   ML Stanly Paul   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1297-1315

Informa Healthcare

Access to resources Recommend Favorite

Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011)

By Deng Xianming   Choi Hwan Geun   Buhrlage Sara J.   Gray Nathanael S.  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1415-1426

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinase CK2 in Human Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. : 1870-1886

Bentham Science Publishers

Access to resources Recommend Favorite